SkinStylus SteriLock MicroSystem Now the Only Microneedling Device with Indications for Facial Acne Scars, Periorbital Wrinkles, and Abdominal Scars

Hydrafacial Treatment Pairing Continues to Drive Adoption of Microneedling Protocols

LONG BEACH, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that the U.S. Food and Drug Administration (FDA) has cleared the SkinStylus microneedling device for the improvement of the appearance of periorbital wrinkles in adults aged 22 years and older for all Fitzpatrick skin types.

This latest clearance expands SkinStylus’ clinically supported indications and reinforces SkinHealth System’s commitment to science-backed innovation within its professional ecosystem.